Dr Reddy#39;s Q3 result: The drugmaker reported a 27% YoY increase in consolidated revenues at Rs 6,770 crore for the reported quarter.
Dr Reddy#39;s Q3 result: The drugmaker reported a 27% YoY increase in consolidated revenues at Rs 6,770 crore for the reported quarter. Dr Reddy#39;s Q3 result: The drugmaker reported a 27% YoY increase in consolidated revenues at Rs 6,770 crore for the reported quarter. Moneycontrol Latest News Read More